First there was Botox, then Dysport, now XEOMIN, and VITAHL is proud to announce that we have been hand selected by Mertz Aesthetics to be an investigational site for the early release of Xeomin.
As the newest FDA approved Botox alternative, Xeomin will be launched in the US in 2012 for cosmetic use. We are ecstatic that we will be receiving Xeomin in November 2011, three months before its release to other medical offices. Xeomin (incobotulinumtoxinA) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, or what we like to call your 11's. It has been used since 2005 in Europe, and results are shown to be comparable to those seen with Botox. While Dysprt is also an alternative to BOTOX, Xeomin's profile is more closely related, making it more of a "Coke-Pepsi" equivalent in the fight against wrinkles.
Our patients will be among the first in the country to compare Xeomin for themselves. We wonder, what will you prefer for eliminating unwanted wrinkles? We are excited to find out!